Figure 3From: Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical doseHaematological parameters in two patients who received 35 or 60 mCi (1295 or 2220 MBq) of 188Re-HEDP (single and multiple dose respectively) vs. timeBack to article page